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Abstract

2

Background: There are few longitudinal studies of vitamin D status from childhood to early

3

adulthood, and it is uncertain whether vitamin D predicts peak bone mass in young adults.

4

Objective: The purpose of this longitudinal study was to evaluate long-term stability of

5

vitamin D status from age 6 to 20 in healthy individuals and to study associations between

6

serum 25-hydroxyvitamin D (25(OH)D) at different developmental stages and bone mass

7

measured at age 20.

8

Design: Participants are offspring of the Western Australian Pregnancy Cohort (Raine) Study.

9

Serum 25(OH)D was assessed at age 6, 14, 17 and 20, and whole body bone mineral content

10

(BMC) and density (BMD) measured at age 20 using dual-energy x-ray absorptiometry

11

(DXA). This analysis included 821 participants (385 females) who had ≥3 serum 25(OH)D

12

measures and DXA data. Using latent class growth analysis, four vitamin D status trajectories

13

were identified: consistently lower (n=259), decreasing (n=125), increasing (n=138), and

14

consistently higher (n=299).

15

Results: There were significant correlations between serum 25(OH)D concentrations at

16

different time points in both sexes (r=0.346-0.560, P<0.001), with stronger correlations at

17

adjacent time points. In males, but not females, serum 25(OH)D at 6, 17 and 20 years was

18

positively associated with total body BMC and BMD at 20 years (covariate-adjusted

19

increments of 40.7-53.9 g and 14.7-18.6 mg/cm2, respectively, per 25 nmol/L 25(OH)D);

20

when 25(OH)D at all four ages were included in the same model, the level at age 6 remained

21

significant. Males in the “consistently higher” trajectory had 3.2-3.4% higher total body

22

BMC and BMD than those who were “consistently lower”, accounting for age,

23

anthropometric and lifestyle factors.

3
24

Conclusion: Within both sexes, there are moderate associations between vitamin D status

25

measured in pre-puberty, adolescence and early adulthood. Vitamin D status in childhood is a

26

significant predictor of peak bone mass in males but not females.

27

Key words: vitamin D status, tracking, early adulthood, peak bone mass, Raine Study

28
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Introduction

30

The physiological importance of vitamin D in calcium homeostasis and bone mineralization

31

is well-established (1), but vitamin D deficiency in children and adolescents is common. In

32

cross-sectional studies, the prevalence of vitamin D deficiency in adolescents ranges from 17

33

to 47% in different countries (2). Even in Australia, a country of low latitude, the 2011-2012

34

National Health Measures Survey showed that 15% of children aged 12-17 years and 31% of

35

adults aged 18-34 years were vitamin D-deficient (defined as serum 25-hydroxy vitamin D

36

(25(OH)D) < 50 nmol/L) (3).

37
38

There is evidence that vitamin D status during childhood and adolescence is associated with

39

bone mineral accretion (4-6), but the results have been inconsistent (7, 8). A 3-year,

40

longitudinal study of Finnish girls aged 9-15 years showed that vitamin D status at baseline

41

had significant correlation with change in bone mineral density (BMD) at the lumbar spine

42

and femoral neck (4). In the Avon Longitudinal Study of Parents and Children, 25(OH)D3

43

measured during childhood (9.9 or 11.8 or 7.6 years) positively associated with cortical bone

44

mineral content, cortical thickness and bone strength measured at 50% mid-tibia using

45

peripheral quantitative computed tomography (pQCT) at 15.5 years (9). However, in a

46

cross-sectional study from Northern Ireland of adolescents aged 12 and 15, higher serum

47

25(OH)D was associated with higher forearm (but not heel) BMD in girls, but not in boys (7),

48

and in a cross-sectional study of American adolescents, there were no significant associations

49

between vitamin D status and bone mass in males or females (8). It is uncertain whether

50

vitamin D status is stable in individuals during childhood and adolescence, and whether a

51

single measurement (as is typical in cross-sectional and longitudinal studies) is a valid long

52

term measure of vitamin D status. In a longitudinal study of 99 South African adolescents

53

followed from age 11 to 20, there was no significant correlation between 25(OH)D in the

5
54

earlier and later years of adolescence, and measurement of 25(OH)D at a single time point

55

did not reflect long term vitamin D status (10). By contrast, a large study of Norwegian adults

56

showed significant correlations between serum 25(OH)D concentrations measured 14 years

57

apart (r = 0.42 to 0.52) (11).

58
59

To our knowledge, tracking of vitamin D status from childhood to early adulthood and its

60

associations with peak bone mass have not been evaluated in a long-term prospective study.

61

In the Western Australian Pregnancy Cohort (Raine) Study, serum 25(OH)D was assessed in

62

the offspring at age 6, 14, 17 and 20 years, and whole body dual-energy x-ray absorptiometry

63

(DXA) scanning was performed at age 20. A longitudinal study of Canadian children showed

64

that whole body peak bone mass was generally achieved by 18.5 years of age in girls and 20

65

years in boys (12). The aims of our study were firstly to determine whether tracking of

66

vitamin D status occurs from childhood to young adulthood, and secondly to examine

67

whether vitamin D status at key developmental stages (childhood, adolescence and skeletal

68

maturity) and vitamin D trajectories are predictors of peak bone mass.
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Subjects and methods

70

Participants

71

This longitudinal, prospective study included data from 821 offspring (436 males and 385

72

females) from the Western Australian Pregnancy Cohort (Raine) Study. The original study

73

recruited 2900 pregnant women from the antenatal clinic at King Edward Memorial Hospital

74

and nearby private clinics in Perth, Western Australia between May 1989 and November

75

1991. Inclusion criteria were a gestational age between 16 and 20 weeks, English language

76

skills sufficient to understand the study demands, an expectation to deliver at King Edward

77

Memorial Hospital, and an intention to remain in Western Australia to enable future follow-

78

up of their child (13). All offspring were invited to attend periodic follow-ups. Compared

79

with the general Western Australian population, the Raine cohort at birth was characterized

80

by higher proportions of high-risk births and fathers employed in managerial and professional

81

positions, but comparison of participants remaining in the study at the 14-year follow-up

82

suggested that attrition resulted in a cohort comparable with the general population (14). A

83

total of 1306 offspring participated in the clinical component of the 20 year follow-up, and

84

1183 had a valid whole body DXA scan. The current study is restricted to participants who

85

had a whole body DXA at 20 years and measurements of serum 25(OH)D at three or more of

86

the study time points at age 6, 14, 17 and 20 years. The study at each follow-up was approved

87

by the Human Research Ethics Committee of Princess Margaret Hospital (year 6, 14 and 17)

88

and University of Western Australia (year 20). At each study visit, written informed consent

89

was obtained from parents and/or offspring, as appropriate.

90
91

Vitamin D status at 6, 14, 17 and 20 years

92

Fasting venous blood was collected at age 6, 14, 17 and 20, and serum was then securely

93

stored at -80°C. Serum 25(OH)D at ages 6 and 14 was measured using an enzyme
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immunoassay (EIA) (Immunodiagnostic Systems (IDS) Ltd, Scottsdale, AZ, USA), whereas

95

at ages 17 and 20, isotope-dilution liquid chromatography/tandem mass spectrometry (LC-

96

MS/MS) was performed by RMIT Drug Discovery Technologies (Melbourne, Victoria,

97

Australia) according to published methodology (15). In 12 participants aged 14 years both

98

methods were used, with a strong correlation (r2 = 0.933) (16). Analysis of 50 samples

99

from participants aged 6 years revealed that EIA overestimated 25(OH)D compared with LC-

100

MS/MS, particularly for 25(OH)D values over 100 nmol/L. Therefore an equation developed

101

using Weighted Deming Regression (17) was used to calculate standardized 25(OH)D values

102

at year 6: standardized 25(OH)D = 22.3 + 0.58 * EIA. Since the enzyme immunoassay at the 6

103

and 14-year follow-ups did not differentiate between serum 25(OH)D2 and 25(OH)D3,

104

analyses at all four time points were performed on total serum 25(OH)D concentrations (18).

105

The inter-assay coefficients of variations (CVs) for the EIA were low standard (40.3 nmol/L)

106

4.6%, medium standard (72.0 nmol/L) 6.4%, and high standard (132.0 nmol/L) 8.7%. For

107

the LC-MS/MS, the CVs for 25(OH)D3 were low standard (27.1 nmol/L) 7.1%, medium

108

standard (75.4 nmol/L) 5.0%, and high standard (163.8 nmol/L) 5.3%; the CVs for

109

25(OH)D2 were low standard (23.4 nmol/L) 8.8%, medium standard (66.0 nmol/L) 6.7%,

110

and high standard (150.1 nmol/L) 6.7%.

111
112

Latent class growth analysis which can discern classes defined by different developmental

113

trajectories was used to estimate trajectories of vitamin D status, in which serum 25(OH)D

114

concentrations at each time point were categorized into four groups according to quartile. Sex

115

was used as an active covariate in the models and a series of models with between 1 and 8

116

trajectories were estimated. Four trajectories were chosen based on a combination of

117

statistical criteria, parsimony and interpretability (19). Participants were assigned to the

118

trajectory class for which they had the highest posterior probability of membership. The four
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vitamin D status trajectories identified were: consistently lower (most values in the two

120

bottom quartiles, n = 259), decreasing (moving from the two top quartiles to the two bottom

121

quartiles over time, n = 125), increasing (moving from the two bottom quartiles to the two

122

top quartiles over time, n =138), and consistently higher (most values in the two top quartiles,

123

n = 299).

124
125

Whole body DXA at 20 years

126

Whole body scanning was performed at the 20 year follow-up visit using DXA on a Norland

127

XR-36 densitometer (Norland Medical Systems, Inc., Fort Atkinson, WI, USA), according to

128

manufacturer-recommended procedures. Analysis of scans was performed using built-in

129

machine software (version 4·3·0) which provided estimates of whole body BMC (g), bone

130

area (cm2) and areal BMD (g/cm2). Daily calibration was performed prior to each scanning

131

session, and the inter-scan coefficient of variation was less than 2%.

132
133

Other assessments

134

At age 6, 14, 17 and 20 years, body weight was measured to the nearest 0.1 kg with subjects

135

dressed in light clothes, and height measured with a hypsometer to the nearest 0.1 cm. Body

136

mass index (BMI) was calculated as weight (kg)/height (m)2, and data on organized sports

137

participation and TV watching collected using a questionnaire. Month and year of menarche

138

in girls were recorded at 14 years. A validated semi-quantitative food frequency

139

questionnaire from the Cancer Council Victoria (20) was used to assess dietary intake

140

including calcium and alcohol intake at 20 years. Physical activity level at 20 years was

141

assessed using the International Physical Activity Questionnaire (IPAQ), and categorized as

142

low, medium and high according to the IPAQ scoring protocol (21). Information on smoking

143

habit and oral contraceptive using in females at 20 years was collected using a questionnaire.
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145

Statistical analysis

146

Variables are presented as mean (SD) unless otherwise stated. The normality of continuous

147

variables was checked through the construction of histograms. The characteristics of

148

participants included in the present study were compared with those of the whole Raine Study

149

cohort to determine whether participants were representative of the broader cohort. These

150

comparisons as well as those between male and female participants were made using

151

Student’s t test and chi-square test. The tracking of vitamin D status was assessed using

152

Pearson’s correlation analysis to calculate the correlation coefficients between serum

153

25(OH)D measured at different time points. In addition, intraclass correlation coefficient

154

(ICC) was obtained from a linear mixed model with 25(OH)D measures at all time points as

155

the dependent variable, age as timeline, subject effects as random and season as covariate (for

156

models with raw values), and the square root of the ICC is given as an estimate of the

157

correlation between any two 25(OH)D measures for the same individual. Associations

158

between serum 25OHD at different ages (6, 14, 17 and 20 years) and total body BMC and

159

BMD at age 20 were evaluated using linear regression analyses in males and females

160

separately, adjusting for covariates including season of blood collection, age, height, body

161

weight, TV watching (22), organized sports participation or physical activity level at the time

162

of 25(OH)D assessment and at age 20, and calcium intake, smoking, alcohol consumption

163

and bone area (for the models for BMC only) at 20 years. To account for seasonal variation

164

of vitamin D status, deseasonalized vitamin D concentrations were calculated using a

165

published formula (23), and the above analyses were repeated using the deseasonalized

166

values (without inclusion of season as a covariate).

167
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Comparisons between those with serum 25(OH)D concentrations below or above the

169

sufficiency level of 50 nmol/L (24) at age 17 and 20 and between the four vitamin D status

170

trajectories (consistently lower, decreasing, increasing, consistently higher) on bone

171

outcomes were made by analysis of covariance (ANCOVA) with Bonferroni post hoc test

172

adjusted for age, height, body weight, physical activity, TV watching, calcium intake,

173

smoking, alcohol consumption and bone area (for BMC only) at 20 years (the models for age

174

17 additionally adjusted for covariates at 17 years). In females, further analyses were made

175

including age of menarche and oral contraceptive use as covariates. The homogeneity of

176

variance of each model was checked by Levene's Test. Statistical significance level was set at

177

P < 0.05 (two-tailed). All analyses were performed using IBM SPSS (version 22, IBM,

178

Chicago, IL, USA) and R (version 3.3.3, R Foundation for Statistical Computing, Vienna,

179

Austria).
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Results

181

Characteristics of participants

182

In total 821 participants (436 males and 385 females) who underwent whole body DXA

183

scanning at age 20 years, and who had measurements of serum 25(OH)D from three or more

184

study visits at age 6, 14, 17 and 20 were included in this analysis (Supplemental Figure 1).

185

Compared with Raine participants who had whole body DXA at 20 years but were not

186

included in the analysis (n = 362), the subsample included in our study (n = 821) did not

187

differ in age, body weight, BMI and total body BMD. The characteristics of participants at 6,

188

14, 17 and 20 are presented in Table 1. Serum 25(OH)D concentrations did not differ

189

significantly between males and females at 6 and 17 years, but at age 14, mean 25(OH)D was

190

significantly higher in males, whereas at age 20 it was higher in females. In girls, the mean

191

age of menarche was 12.8 ± 1.1 years, and at age 20, 56.5% of females were using an oral

192

contraceptive.

193
194

Tracking of vitamin D status

195

There were significant correlations between serum 25(OH)D concentrations measured at

196

different time points in both males (raw values r = 0.360−0.560; deseasonalized values r =

197

0.440−0.673, all P<0.001) and females (raw values r = 0.346−0.537; deseasonalized values r

198

= 0.399−0.629, P<0.001), and the associations were stronger at adjacent time points (Table

199

2). The square root of ICC range was 0.667-0.697 for these values (Table 2), and were very

200

similar (0.684 for males and 0.667 for females) when using the unstandardized (measured)

201

values at year 6 in the models. When analyzed according to whether serum 25(OH)D was

202

below or above the median at age 6, it was found that the majority of participants (64.4-69.7%

203

of males and 58.9-66.5% of females) remained in the same group (i.e. below or above the

204

median) at age 14, 17 and 20 (Supplemental Table 1).
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206

Relationship between vitamin D status and peak bone mass

207

In males, serum 25(OH)D concentration using the raw values at age 6, 17 and 20 years was

208

positively associated with total body BMC and BMD at age 20, with regression coefficients

209

of 40.7-53.9 g for BMC and 14.7-18.6 mg/cm2 for BMD per 25 nmol/L increase in 25(OH)D

210

(all P<0.05) after adjustment for season of blood collection, age, height, weight, TV watching,

211

organized sports participation or physical activity level at the time of 25(OH)D assessment

212

and at age 20, and calcium intake, smoking, alcohol consumption and bone area (for BMC

213

only) at age 20 (Table 3). When measured (unstandardized) 25(OH)D values at year 6 were

214

used instead for the year 6 models, the regression coefficient (95% CI) was slightly lower as

215

31.3 (3.6, 59.0) g for BMC, and 10.8 (1.1, 20.5) mg/cm2 for BMD. Serum 25(OH)D

216

concentrations at age 14 in males and at age 6, 14, 17 and 20 in females were not

217

significantly correlated with total body bone measures at 20 years (Table 3). In females, the

218

results remained similar after further adjustment for age of menarche and oral contraceptive

219

use (data not shown). Using deseasonalized 25(OH)D values yielded similar results (Table 3).

220
221

In a further regression model in males where 25(OH)D at the four different ages were

222

simultaneously included, only 25(OH)D at year 6 remained significant, with regression

223

coefficient (95% CI) of 50.6 (6.7, 94.4) g for BMC, and 18.1 (2.6, 33.6) mg/cm2 for BMD per

224

25 nmol/L increase in serum 25(OH)D. When measured (unstandardized) 25(OH)D values at

225

year 6 were used instead, the regression coefficient (95% CI) was slightly lower at 29.3 (3.9,

226

54.8) g for BMC, and 10.5 (1.5, 19.5) mg/cm2 for BMD. Using deseasonalized 25(OH)D

227

values yielded similar results (data not shown).

228
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There were 1.0%, 3.9%, 15.4% and 16.7% participants with serum 25(OHD) below 50

230

nmol/L at age 6, 14, 17 and 20, respectively. Comparing to those with serum 25(OHD) below

231

50 nmol/L, those with serum 25(OHD) ≥ 50 nmol/L had 3.8-4.1% higher total body BMC

232

and BMD at age 17 and 20 (Table 4).

233
234

Vitamin D trajectories and peak bone mass

235

The mean serum 25(OH)D values at each time point for the four vitamin D status trajectories

236

identified (consistently lower, decreasing, increasing and consistently higher) are presented

237

in Figure 1. At age 20, males in the “consistently higher” vitamin D trajectory had 3.2% and

238

3.4% higher total body BMC and BMD, respectively, compared with those in the

239

“consistently lower” category, after accounting for age, height, body weight, physical activity,

240

TV watching, calcium intake, smoking, alcohol consumption and bone area (for BMC only)

241

at 20 years (BMC 3222 ± 21 vs 3123 ± 24 g, P = 0.013; BMD 1135 ± 7 vs 1098 ± 8 mg/cm2,

242

P = 0.008) (Figure 2). In females, there were no significant differences between the four

243

trajectory classes in total body bone measures at 20 years after adjustment for these

244

covariates (Figure 2), or after further adjustment for age of menarche and oral contraceptive

245

use (data not shown).
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Discussion

247

In this longitudinal study of 821 boys and girls examined at age 6, 14, 17 and 20, we found

248

evidence of tracking of vitamin D status, with significant associations between vitamin D in

249

individuals assessed at pre-puberty, adolescence and early adulthood in both genders. In

250

males, but not females, serum 25(OH)D at age 6, 17 and 20 was a significant predictor of

251

total body BMC and BMD at 20 years, with the level at age 6 remaining significant when

252

25(OH)D at four different ages were included in the same model. Males in the “consistently

253

higher” vitamin D trajectory had significantly higher total body BMC and BMD than those in

254

the “consistently lower” category, after accounting for age, anthropometric and lifestyle

255

factors. Childhood and adolescence are critical periods for bone mineral accretion, and

256

achieving optimal peak bone mass at skeletal maturity is considered an effective strategy

257

against osteoporosis in later life. An increase in peak bone mass by one standard deviation is

258

estimated to reduce the osteoporotic fracture risk in later life by 50% (25). Therefore the

259

magnitude of the difference observed in total body BMD in our study (~0.35 SD) may be

260

clinically relevant, with implications for reducing the fracture risk in later life.

261
262

Vitamin D has well-established physiological roles in calcium absorption and bone

263

mineralization, and an association between vitamin D status in childhood/adolescence and

264

peak bone mass is biologically plausible. The basis for the sex difference observed in the

265

present study is uncertain, but may arise from differences in sex hormone effects in bone

266

between males and females. Estrogens and androgens influence the growth and maintenance

267

of bones and muscles and are responsible for sexual dimorphism. Estrogen is needed for

268

closure of epiphyseal growth plates in both sexes (26), and the more rapid epiphyseal

269

maturation in girls compared with boys is mostly due to higher circulating estradiol levels

270

(27). Estrogen stimulates renal 1- hydroxylase activity, converting 25(OH)D to the more

15
271

biologically active hormone 1,25(OH)2D (28), stimulates vitamin D receptor expression via

272

activation of the ERK 1/2 signaling pathway (29), and increases intestinal calcium absorption

273

through vitamin D-dependent, and possibly vitamin D-independent mechanisms (30).

274

Estrogen also reduces circulating levels of sclerostin, an inhibitor of Wnt signaling, which

275

has anti-anabolic effects on bone (31). It is thus possible that in females, estrogenic effects

276

may counteract the effects of lower 25(OH)D levels, whereas in males this compensatory

277

effect is absent, explaining the sex difference in our results. In the same cohort, associations

278

between vitamin D status, atopy and asthma at age 6 and 14 years were seen mainly in boys

279

(16). Another possible explanation is that males experience a longer period of bone mineral

280

accretion and require a greater amount of calcium than females (12), and therefore may be

281

more at risk from suboptimal intestinal calcium absorption associated with lower vitamin D

282

levels. Consistent with our findings, in a Korean study of 1926 men and 2350 women aged

283

10-40 years, significant positive associations between serum 25(OH)D and BMD of spine

284

and hip were observed in men but not women (32).

285
286

The significant, moderate correlations observed between serum 25(OH)D concentrations at

287

age 6, 14, 17 and 20 in our West Australian cohort differ from a study of South African

288

adolescents, in which no association was found between 25(OH)D values measured in early

289

and late adolescence (10). Our results are consistent with data from Norwegian adults, in

290

whom, after seasonal adjustment, the correlation coefficients of serum 25(OH)D

291

concentrations measured 14 years apart ranged between 0.42 to 0.52, similar to those seen for

292

cardiovascular risk factors, blood pressure and lipids (11), and close to the coefficients

293

observed in our study. In the majority of our participants, vitamin D status at 6 years with

294

respect to the quartile they were in predicted their vitamin D status at subsequent visits. Such

295

tracking in vitamin D status from childhood to young adulthood may be due to multiple

16
296

factors known to affect vitamin D status, including genetic factors, body fatness, and lifestyle

297

factors such as dietary intake and sunlight exposure (18, 33). In a meta-analysis of six

298

randomized controlled trials of vitamin D supplementation in healthy children, there was no

299

significant effect of vitamin D on BMC or BMD overall, but there was a significant positive

300

effect on total body BMC in children with low baseline 25(OH)D levels (<35 nmol/L) (34).

301

Therefore, optimizing vitamin D status in children and adolescents could play an important

302

role in promoting the attainment of optimal peak bone mass.

303
304

A strength of this study is the measurement of serum 25(OH)D at multiple time points,

305

allowing the longitudinal analysis of vitamin D at different developmental stages and use of

306

trajectories as predictors of peak bone mass. Other strengths include the large sample size,

307

prospective, detailed data collection and assessment of bone mass at the age of accrual of

308

peak bone mass (12). Our study also has limitations. Firstly, its observational nature means

309

we cannot assume that the relationships between vitamin D status and bone are causal.

310

Although we adjusted for important confounding variables including anthropometric

311

measures and lifestyle factors, the significant associations observed may be due to potential

312

residual or uncontrolled confounders. Secondly, the majority of participants were Caucasian,

313

with median serum 25(OH)D concentrations between 70 and 80 nmol/L at different time

314

points; the study findings may not be applicable to other ethnic groups or communities with

315

substantially different vitamin D status. Thirdly, two different methods were used to measure

316

serum 25(OH)D. This may affect measured 25(OH)D values, but should have minimal or no

317

effect on ranking and trajectory. In addition, we used standardized values at age 6 to correct

318

for between-method differences and also presented analyses results using unstandardized

319

values, whereas at age 14 there was good agreement between the methods. Finally, we did

320

not measure BMD at fracture-relevant sites such as spine and hip, but previous studies have

17
321

shown the value of total body BMD in predicting hip fracture (35) and a close relationship

322

between BMD measures of total body, lumbar spine and hip (36).

323
324

In conclusion, we found moderate associations between serum 25(OH)D measured at pre-

325

puberty, adolescence and early adulthood in both genders, and evidence of tracking of

326

vitamin D status across key developmental stages. In males, but not females, vitamin D status

327

in childhood and adolescence was a significant, independent predictor of peak bone mass at

328

age 20. Optimizing vitamin D status during childhood may play a role in achievement of

329

optimal peak bone mass, particularly in males, which may in turn reduce the risk of fracture

330

in adult life.
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Table 1 Characteristics of male and female participants at each time point
P1

Male

Female

n = 271

n = 228

Age, year

5.9 ± 0.2

5.9 ± 0.2

0.822

Weight, kg

21.4 ± 3.6

20.9 ± 2.8

0.031

Height, cm

116.1 ± 5.1

115.5 ± 4.5

0.186

25(OH)D measured, nmol/L

105.4 ± 34.3

101.2 ± 28.8

0.138

25(OH)D standardized, nmol/L

83.4 ± 19.9

81.0 ± 16.7

0.138

25(OH)D deseasonalized, nmol/L

83.2 ± 18.9

81.3 ± 15.7

0.226

Watch TV ≥ 2 hours/day, %

25.1

19.2

0.057

Participated in organized sports, %

35.9

32.6

0.363

n = 412

n = 366

Age, year

14.1 ± 0.2

14.1 ± 0.2

0.285

Weight, kg

57.4 ± 12.6

56.0 ± 10.4

0.091

Height, cm

165.9 ± 8.5

162.8 ± 6.3

<0.001

25(OH)D, nmol/L

89.6 ± 31.0

83.7 ± 28.6

0.005

25(OH)D deseasonalized, nmol/L

89.9 ± 26.6

83.3 ± 25.4

<0.001

Watch TV ≥ 2 hours/day, %

47.7

44.5

0.391

Participated in organized sports, %

94.0

87.6

0.002

n = 409

n = 366

Age, year

17.0 ± 0.2

17.1 ± 0.3

0.037

Weight, kg

70.7 ± 13.2

62.8 ± 10.9

<0.001

Height, cm

177.5 ± 7.0

166.7 ± 6.6

<0.001

25(OH)D, nmol/L

74.7 ± 28.6

75.1 ± 26.2

0.857

25(OH)D deseasonalized, nmol/L

75.4 ± 25.2

75.1 ± 23.9

0.871

6 years

14 years

17 years

25

Watch TV ≥ 2 hours/day, %

31.3

28.8

0.497

Participated in organized sports, %

85.5

72.3

<0.001

n = 436

n = 385

Age, year

20.0 ± 0.4

20.0 ± 0.4

0.312

Weight, kg

76.8 ± 14.1

65.5 ± 12.7

<0.001

Height, cm

178.3 ± 7.1

166.3 ± 6.4

<0.001

BMI, kg/m2

24.1 ± 3.9

23.7 ± 4.6

0.198

25(OH)D, nmol/L

70.6 ± 24.3

75.2 ± 26.2

0.009

25(OH)D deseasonalized, nmol/L

71.3 ± 22.2

75.6 ± 24.8

0.010

26.5

26.1

0.931

Low

8.0

13.1

<0.001

Moderate

33.6

52.6

High

58.4

34.4

Current smoker, %

15.6

12.5

0.274

Alcohol intake ≥3 units/day, %

16.6

4.6

<0.001

1029.6 ± 435.8

803.4 ± 334.9

<0.001

Total body BMC, g

3182 ± 429

2719 ± 325

<0.001

Total body bone area, cm2

2830 ± 192

2649 ± 181

<0.001

Total body BMD, mg/cm2

1122 ± 107

1025 ± 83

<0.001

20 years

Watch TV ≥ 2 hours/day, %
Physical activity, %

Calcium intake, mg/day

Values are mean ± SD unless otherwise stated. 25(OH)D, 25 hydroxyvitamin D; BMC, bone
mineral content; BMD, bone mineral density.
1

Student’s t-test or chi-square test.
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Table 2 Correlations between individual participants’ 25(OH)D concentrations
measured at 6, 14, 17 and 20 years
Raw values

Deseasonalized values

Year 14

Year 17

Year 20

Year 14

Year 17

Year 20

Male

n = 412

n = 409

n = 422

n = 412

n = 409

n = 422

Year 6 (n = 271)

0.4411

0.455 1

0.399 1

0.483 1

0.473 1

0.440 1

0.560 1

0.360 1

0.577 1

0.483 1

Year 14 (n = 412)

0.501 1

Year 17 (n = 409)
Square root of ICC 2

0.673 1

0.667

0.691

Female

n = 366

n = 366

n = 371

n = 366

n = 366

n = 371

Year 6 (n = 228)

0.473 1

0.394 1

0.358 1

0.493 1

0.430 1

0.399 1

0.412 1

0.346 1

0.463 1

0.487 1

Year 14 (n = 366)

0.537 1

Year 17 (n = 368)
Square root of ICC 2

0.667

0.629 1
0.697

1

P < 0.001, Pearson correlation coefficients.

2

Square root of ICC (intraclass correlation coefficient) obtained from linear mixed model with

subject effects as random, age as timeline and adjusted for season for raw values.
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Table 3 Associations between serum 25-hydroxyvitamin D at each time point and 20 year total body bone measures
Regression coefficients (95% CI) per 25 nmol/L increase in serum 25(OH)D concentration
Year 6

Year 14

Year 17

Year 20

(M = 271, F = 228)

(M = 412, F = 366)

(M = 409, F = 366)

(M = 422, F = 371)

53.9 (6.2, 101.6) 1

12.8 (-10.6, 36.2)

40.7 (13.5, 68.0)

43.5 (12.0, 74.9)

18.6 (1.9, 35.3)

4.7 (-3.5, 13.0)

14.7 (5.1, 24.3)

15.7 (4.7, 26.7)

Total body BMC, g

48.4 (0.01, 96.8)

6.0 (-19.8, 31.9)

42.6 (13.4, 71.7)

38.8 (6.1, 71.6)

Total body BMD, mg/cm2

16.6 (-0.3, 33.5)

2.2 (-6.9, 11.3)

15.2 (5.0, 25.5)

14.0 (2.6, 25.5)

Total body BMC, g

2.4 (-39.8, 44.6)

1.6 (-16.4, 19.7)

-8.1 (-31.1, 14.8)

7.9 (-13.0, 28.8)

Total body BMD, mg/cm2

1.1 (-15.1, 17.2)

0.02 (-6.9, 6.9)

-2.2 (-11.0, 6.6)

2.7 (-5.2, 10.7)

Male (raw values)
Total body BMC, g
2

Total body BMD, mg/cm

Male (deseasonalized values)

Female (raw values)

Female (deseasonalized values)
Total body BMC, g

-5.2 (-50.6, 40.2)

5.5 (-14.0, 25.0)

-4.3 (-27.5, 19.0)

6.1 (-14.9, 27.2)

Total body BMD, mg/cm2

-2.4 (-19.7, 14.9)

1.2 (-6.3, 8.7)

-0.8 (-9.6, 8.1)

2.1(-5.9, 10.1)

BMC, bone mineral content; BMD, bone mineral density.
1

Multiple linear regression models adjusted for age, height, weight, TV watching, organised sports participation or physical

activity level at time of 25(OH)D measurement and 20 year, calcium intake, smoking, and alcohol consumption at 20 years, and
additionally adjusted for bone area for the models for BMC and season of blood collection for models using raw values.
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Table 4 Comparisons between those with 25-hydroxyvitamin D below or above 50
nmol/L at 17 and 20 years and total body bone measures at age 20
25(OH)D at year 17

25(OH)D at year 20

<50 nmol/L

≥50 nmol/L

<50 nmol/L

≥50 nmol/L

65

344

76

346

Total body BMC, g

3106 ± 37

3226 ± 16 1

3096 ± 32

3215 ± 15 2

Total body BMD, mg/cm2

1094 ± 13

1136 ± 6 1

1088 ± 11

1133 ± 5 2

54

312

56

315

Total body BMC, g

2672± 30

2718 ± 12

2701 ± 29

2707 ± 11

Total body BMD, mg/cm2

1006 ± 11

1025 ± 5

1018 ± 11

1023 ± 4

Male, n

Female, n

Values are estimated mean ± SEM. BMC, bone mineral content; BMD, bone mineral
density.
1

P = 0.004, 2 P = 0.001 compared with 25(OH)D < 50 nmol/L at the same age, analysis of

covariance (ANCOVA) adjusted for season of blood collection, age, height, weight, TV
watching, organised sports participation or physical activity level at time of 25(OH)D
measurement and 20 year, calcium intake, smoking, and alcohol consumption at 20 years,
and additionally adjusted for bone area for the models for BMC.

Figure legends

Figure 1 Mean serum 25-hydroxy vitamin D (25(OH)D) both sexes combined at each time
point by trajectory classes, error bar represents standard deviation.

Figure 2 Comparison of estimated means of total body bone mineral content (BMC) and
density (BMD) by vitamin D status trajectory classes. N = 136, 62, 64 and 174 for males and
123, 63, 74 and 125 for females in the consistently lower, decreasing, increasing and
consistently higher groups, respectively. Error bar represents standard error, analysis of covariance with Bonferroni post hoc test, adjusted for age, height, body weight, bone area (for
the models for BMC only), physical activity, TV watching, calcium intake, smoking and
alcohol consumption at 20 years.

Figure 1

Figure 2

